JPRN-jRCT1031210554招募中未知
A study on the efficacy of the loss of response to jaw thrust as a clinical test to assess adequate depth of anesthesia using remimazolam besylate and the dose required for the loss of response.
Okuda Yasuhisa0 个研究点目标入组 70 人开始时间: 2022年1月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •1) Patients with written consent to participate in this study.
- •2) Patients aged between 20 and 65 at the time of consent.
- •3) American Society of Anesthesiologists (ASA) Grade I or II patients.
- •4) Patients whose surgical purpose is other than heart surgery.
排除标准
- •1) Patients undergoing emergency surgery.
- •2) Patients who may be pregnant.
- •3) Patients who are expected to have difficulty airway management or intubation.
- •4) BMI 28 and above.
- •5) Patients who have high risk of aspiration.
- •6) Patients with liver dysfunction: Child-pugh classification B or higher.
- •7) Patients with contraindications to propofol or remimazolam.
- •8) Patients with a history of alcoholism or drug abuse.
- •9) Patients who regularly use sedatives.
- •10) Patients with a history of cervical spine / cervical cord disease.
- •11) Patients with no eyelashes.
- •12) Patients with a history of cranial nerve system disease.
研究者
相似试验
已完成
不适用
Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis CChronic hepatitis CJPRN-UMIN000017560Hokkaido University30
尚未招募
3 期
Evaluation of the response and adverse effects of total neoadjuvant therapy (TNT) of advanced localized rectal cancerC18.7Rectal cancer.Malignant neoplasm of sigmoid colonIRCT20120215009014N431Hamedan University of Medical Sciences25
进行中（未招募）
1 期
Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccinatioCOVID19 vaccine in kidney transplant patientsMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865MedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 100000004865EUCTR2021-002356-37-ESFundació Clinic per a la Recerca Biomèdica (FCRB)80
已完成
不适用
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
已完成
不适用
The Effect of the Prevention Education Program on Performance of Parents.IRCT2017053034226N1Deputy of Research and Technology of Arak University of Medical Sciences150